Latest News

Easy and effective therapy to restore sight: Engineered virus will improve gene therapy for blinding eye diseases

Gene therapy using adeno-associated virus has successfully restored sight to people with a rare inherited retinal degeneration, but current therapy requires injecting the virus directly into the retina. Researchers have now caused AAV to evolve so that it is able to penetrate the retina, allowing doctors to inject the virus and its gene load into the vitreous to reach all cells of the retina. This broadens AAV's potential application to more common types of vision loss.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Humiliation tops list of mistreatment toward med students

  • Researchers examine effectiveness of blocking nerve to help with weight loss

  • Economic success drives language extinction

  • Mouse model provides window into working brain

  • Plain cigarette packs don't hurt small retailers or boost trade in illicit tobacco

  • High dietary salt may worsen multiple sclerosis symptoms

  • How Alzheimer's peptides shut down cellular powerhouses

  • Real tremors, or drug-seeking patient? New app can tell

  • Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms

  • Nucleotide change could initiate Fragile X Syndrome

  •